Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy

This publication has 40 references indexed in Scilit:

• Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells
  Oncogene, 2002
• Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia
  Leukemia, 2002
• Adenovirus-mediated overexpression of p14ARF induces p53 and Bax-independent apoptosis
  Oncogene, 2002
• Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins
  Cell Death & Differentiation, 2002
• Analysis of p53/BAX in primary colorectal carcinoma: Low BAX protein expression is a negative prognostic factor in UICC stage III tumors
  International Journal of Cancer, 2002
• The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines
  Oncogene, 2002
• Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance
  Oncogene, 2001
• Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo
  Leukemia, 2000
• Impaired BAX protein expression in breast cancer: Mutational analysis of the BAX and thep53 gene
  International Journal of Cancer, 2000
• Twenty years of p53 research: structural and functional aspects of the p53 protein
  Oncogene, 1999